中文简体
中文繁体
English
ABOUT IASO
Company Overview
Management Team
Scientific Advisory Board
Partnership
SCIENCE & PRODUCTS
Pipeline
Technology Platforms
Manufacturing
Publictaions
Expanded Access
NEWS
Press Release
Media Report
CAREERS
Working at IASO
Opportunities
CONTACT
NEWS
Press Release
Media Report
Search
20/11
2025
GC Cell introduces multiple myeloma CAR-T therapy from China's IASO Biotech
01/07
2025
IASO Bio's Equecabtagene Autoleucel Gains First Approval Outside Mainland China
28/03
2025
Macau approves IASO Bio's multiple myeloma therapy
12
2024-08
IASO Bio Receives U.S. FDA Approval Of Investigational New Drug Application For Equecabtagene Autoleucel For Two New Autoimmune Disease Indications
17
2023-01
IASO Bio Raises Nearly $75 Million in Series C1 Funding
23
2021-09
Fierce Biotech | China's IASO nets $108M to advance cell therapies, antibodies for cancer, autoimmune disease
12
2021-08
PRECISIOIN ONCOLOGY NEWS: In Brief This Week-IASO Biotherapeutics, Genentech, BioNTech
09
2021-06
Trailing the Big Pharma players, a lesser known BCMA CAR-T candidate comes into the spotlight
23
2019-11
IASO Bio to Present at ASH 2019
01
2019-09
IASO Bio to Present at IMWG 2019
<
1
2
>
